Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Time will tell how the GLP-1 agonist saga unfolds
Problems paying for prescription drugs Source: Montero, et al KFF, November 14, 2025 Implications for employers: Plan member interest in GLP-1 medications to treat obesity and cardiometabolic disease is likely to continue to increase
CONTACT: Phone: 888-896-1612 Email: [email protected]
According to the brand's Terms of Service, healthcare providers using the platform are independent medical professionals responsible for the medical care they provide, and a prescription is only issued if a provider determines treatment is clinically appropriate
Using much smaller amounts than clinical doses to test personal tolerance and reduce side effects
US$ 24.39
US$ 26.11
US$ 27.74
US$ 24.50
US$ 21.88
US$ 20.64
US$ 23.74
US$ 24.35
US$ 23.37
